EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences

Priyanka Kandhare, Mrunal Kurlekar, Tanvi Deshpande, Atmaram Pawar

Drugs and Drug Candidates · 04.03.2025 · 4 (1) · 9

DOI: 10.3390/ddc4010009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs and Drug Candidates, online erschienen am 04.03.2025. Verfasst von Priyanka Kandhare und 3 weiteren Autor:innen. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The integration of Artificial Intelligence (AI) and Machine Learning (ML) in pharmaceutical research and development is transforming the industry by improving efficiency and effectiveness across drug discovery, development, and healthcare delivery. This review explores the diverse applications of AI and ML, emphasizing their role in predictive modeling, drug repurposing, lead optimization, and clinical trials. Additionally, the review highlights AI’s contributions to regulatory compliance, pharmacovigilance, and personalized medicine while addressing ethical and regulatory considerations.

Methods

A comprehensive literature review was conducted to assess the impact of AI and ML in various pharmaceutical domains. Research articles, case studies, and industry reports were analyzed to examine AI-driven advancements in predictive modeling, computational chemistry, clinical trials, drug safety, and supply chain management.

Results

AI and ML have demonstrated significant advancements in pharmaceutical research, including improved target identification, accelerated drug discovery through generative models, and enhanced structure-based drug design via molecular docking and QSAR modeling. In clinical trials, AI streamlines patient recruitment, predicts trial outcomes, and enables real-time monitoring. AI-driven predictive maintenance, process optimization, and inventory management have enhanced efficiency in pharmaceutical manufacturing and supply chains. Furthermore, AI has revolutionized personalized medicine by enabling precise treatment strategies through genomic data analysis, biomarker discovery, and AI-driven diagnostics.

Conclusions

AI and ML are reshaping pharmaceutical research, offering innovative solutions across drug discovery, regulatory compliance, and patient care. The integration of AI enhances treatment outcomes and operational efficiencies while raising ethical and regulatory challenges that require transparent, accountable applications. Future advancements in AI will rely on collaborative efforts to ensure its responsible implementation, ultimately driving the continued transformation of the pharmaceutical sector.

Zitieren

APA

Kandhare, P., Kurlekar, M., Deshpande, T., & Pawar, A. (2025). A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences. Drugs and Drug Candidates, 4(1), 9. https://doi.org/10.3390/ddc4010009

Vancouver

Kandhare P, Kurlekar M, Deshpande T, Pawar A. A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences. Drugs and Drug Candidates. 2025;4(1):9. doi:10.3390/ddc4010009

BibTeX
@article{Kandhare2025,
  author = {Kandhare, Priyanka and Kurlekar, Mrunal and Deshpande, Tanvi and Pawar, Atmaram},
  title = {A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences},
  journal = {Drugs and Drug Candidates},
  year = {2025},
  volume = {4},
  number = {1},
  pages = {9},
  doi = {10.3390/ddc4010009}
}
Kostenlos starten →